| Stephanie Marie Harris, MD | |
|
800 Mercy Dr Ste 110, Council Bluffs, IA 51503 | |
| (712) 388-2860 | |
| Not Available |
| Full Name | Stephanie Marie Harris |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 800 Mercy Dr Ste 110, Council Bluffs, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457762148 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Clinic Inc | 4880506062 | 497 |
News Archive
Cancer Research Technology (CRT), the specialist oncology development and commercialisation company, and Stealthyx Therapeutics, the disease targeting drug company spin out of Queen Mary, University of London have entered into an agreement to co-develop Stealthyx's proprietary drug delivery platform, Prothyx.
OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.
A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.
A study examining doctor and patient behavior at three Johns Hopkins Medicine outpatient clinics has found evidence that clinicians spend more face-to-face time with patients when the clinic is on schedule and less when the clinic is running late.
The association between weight and causes of death can vary considerably, with obesity associated with a significantly increased mortality from cardiovascular disease (CVD), underweight associated with increased mortality from primarily non-cancer, non-CVD causes, and overweight associated with increased mortality from diabetes and kidney disease combined, but with reduced mortality from other non-cancer non-CVD causes of death, according to a study in the November 7 issue of JAMA.
› Verified 6 days ago
| Entity Name | Physicians Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20031105000345 |
News Archive
Cancer Research Technology (CRT), the specialist oncology development and commercialisation company, and Stealthyx Therapeutics, the disease targeting drug company spin out of Queen Mary, University of London have entered into an agreement to co-develop Stealthyx's proprietary drug delivery platform, Prothyx.
OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.
A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.
A study examining doctor and patient behavior at three Johns Hopkins Medicine outpatient clinics has found evidence that clinicians spend more face-to-face time with patients when the clinic is on schedule and less when the clinic is running late.
The association between weight and causes of death can vary considerably, with obesity associated with a significantly increased mortality from cardiovascular disease (CVD), underweight associated with increased mortality from primarily non-cancer, non-CVD causes, and overweight associated with increased mortality from diabetes and kidney disease combined, but with reduced mortality from other non-cancer non-CVD causes of death, according to a study in the November 7 issue of JAMA.
› Verified 6 days ago
| Entity Name | Alegent Creighton Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548287907 PECOS PAC ID: 1951210418 Enrollment ID: O20040407001314 |
News Archive
Cancer Research Technology (CRT), the specialist oncology development and commercialisation company, and Stealthyx Therapeutics, the disease targeting drug company spin out of Queen Mary, University of London have entered into an agreement to co-develop Stealthyx's proprietary drug delivery platform, Prothyx.
OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.
A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.
A study examining doctor and patient behavior at three Johns Hopkins Medicine outpatient clinics has found evidence that clinicians spend more face-to-face time with patients when the clinic is on schedule and less when the clinic is running late.
The association between weight and causes of death can vary considerably, with obesity associated with a significantly increased mortality from cardiovascular disease (CVD), underweight associated with increased mortality from primarily non-cancer, non-CVD causes, and overweight associated with increased mortality from diabetes and kidney disease combined, but with reduced mortality from other non-cancer non-CVD causes of death, according to a study in the November 7 issue of JAMA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Marie Harris, MD 7261 Mercy Rd, Omaha, NE 68124-2311 Ph: (712) 388-2860 | Stephanie Marie Harris, MD 800 Mercy Dr Ste 110, Council Bluffs, IA 51503 Ph: (712) 388-2860 |
News Archive
Cancer Research Technology (CRT), the specialist oncology development and commercialisation company, and Stealthyx Therapeutics, the disease targeting drug company spin out of Queen Mary, University of London have entered into an agreement to co-develop Stealthyx's proprietary drug delivery platform, Prothyx.
OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.
A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.
A study examining doctor and patient behavior at three Johns Hopkins Medicine outpatient clinics has found evidence that clinicians spend more face-to-face time with patients when the clinic is on schedule and less when the clinic is running late.
The association between weight and causes of death can vary considerably, with obesity associated with a significantly increased mortality from cardiovascular disease (CVD), underweight associated with increased mortality from primarily non-cancer, non-CVD causes, and overweight associated with increased mortality from diabetes and kidney disease combined, but with reduced mortality from other non-cancer non-CVD causes of death, according to a study in the November 7 issue of JAMA.
› Verified 6 days ago
Amy L Ford, ARNP Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 900 S 6th St, Council Bluffs, IA 51501 Phone: 712-325-1990 | |
Brittany Victoria Simon, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1288 Valley View Dr, Council Bluffs, IA 51503 Phone: 712-328-8800 | |
Dr. Erik N Schulte, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St Ste 312, Council Bluffs, IA 51503 Phone: 712-396-7800 Fax: 712-396-7885 | |
Dr. Maureen A Boyle-manganaro, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St, Ste 312, Council Bluffs, IA 51503 Phone: 712-396-7880 Fax: 712-396-7885 | |
Jorge L Garcia-padial, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 201 Ridge St, #307, Council Bluffs, IA 51503 Phone: 712-329-5700 Fax: 712-329-5759 | |
Ada I Ortiz-bianchi, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St, #307, Council Bluffs, IA 51503 Phone: 712-329-5700 Fax: 712-329-5759 |